These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15559003)

  • 1. Oral drug therapy for erectile dysfunction: overview and aeromedical implications.
    Grossman A; Barenboim E; Azaria B; Sherer Y; Goldstein L
    Aviat Space Environ Med; 2004 Nov; 75(11):997-1000. PubMed ID: 15559003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erectile dysfunction.
    Singh JC; Devasia A; Gnanaraj L; Chacko KN
    Natl Med J India; 2005; 18(3):139-43. PubMed ID: 16130616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].
    Bryniarski L; Rzepecki M; Klocek M; Wyczołkowski M
    Przegl Lek; 2009; 66(4):192-7. PubMed ID: 19708509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction.
    Axilrod AC
    Curr Med Res Opin; 2007 Dec; 23(12):3189-98. PubMed ID: 17991309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury.
    Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wilkins HJ; Wachs BH;
    Neurology; 2006 Jan; 66(2):210-6. PubMed ID: 16434656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; Saccà A; Montorsi P; Rigatti P; Montorsi F
    Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).
    Montorsi F; Padma-Nathan H; Glina S
    Urology; 2006 Sep; 68(3 Suppl):26-37. PubMed ID: 17011373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily use of phosphodiesterase 5 inhibitors for erectile dysfunction and lower urinary tract symptoms.
    Pimentel H; Wald M; Niederberger C
    Int J Impot Res; 2008; 20(2):145-9. PubMed ID: 18075506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From the Cochrane Library: Phosphodiesterase inhibitors are effective in treating erectile dysfunction in diabetic men].
    Hamerlynck JV; Middeldorp S; Hooft L
    Ned Tijdschr Geneeskd; 2007 Sep; 151(38):2101-4. PubMed ID: 17948826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer phosphodiesterase inhibitors: comparison with established agents.
    McNamara ER; Donatucci CF
    Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients.
    Schwarz ER; Rastogi S; Rodriguez JJ; Kapur V; Sulemanjee N; Gupta R; Rosanio S
    Int J Impot Res; 2005 Dec; 17 Suppl 1():S37-43. PubMed ID: 16391541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral sildenafil demonstrates the effectiveness and well tolerance in the treatment of patients with erectile dysfunction].
    Shang XJ; Huang YF
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):877-9. PubMed ID: 16333970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of erectile dysfunction in man.
    Cirino G; Fusco F; Imbimbo C; Mirone V
    Pharmacol Ther; 2006 Aug; 111(2):400-23. PubMed ID: 16443277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment.
    Gazzaruso C
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):173-80. PubMed ID: 16509813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of erectile dysfunction after cancer treatment.
    Peltier A; van Velthoven R; Roumeguère T
    Curr Opin Oncol; 2009 Jul; 21(4):303-9. PubMed ID: 19509501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vardenafil provides reliable efficacy over time in men with erectile dysfunction.
    Montorsi F; Hellstrom WJ; Valiquette L; Bastuba M; Collins O; Taylor T; Thibonnier M; Homering M; Eardley I;
    Urology; 2004 Dec; 64(6):1187-95. PubMed ID: 15596195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile dysfunction.
    Lewis JM; Osbourne AL; O'Leary MP
    J Med Liban; 2004; 52(4):213-6. PubMed ID: 16432984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update of PDE5 inhibitors as treatment of ED].
    Lu YN; Chen B
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):552-5. PubMed ID: 16078679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.